Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...
By 193cc Agency CouncilApril 5, 2024In the dynamic world of pharmaceuticals, the journey of Xu Jiangnan stands out as a beacon of innovation, perseverance, and strategic foresight. As...
By 193cc World's BillionairesMarch 5, 2024In the ever-evolving landscape of global healthcare, few figures have made as indelible a mark as Feng Yuxia, the visionary chair of Joinn...
By 193cc World's BillionairesFebruary 27, 2024